Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY.

Wong DT, Lambrou GN, Loewenstein A, Pearce I, Okada AA.

Retina. 2019 Dec 24. doi: 10.1097/IAE.0000000000002713. [Epub ahead of print]

PMID:
31876889
2.

EFFECT OF INVERTED INTERNAL LIMITING MEMBRANE FLAP ON CLOSURE RATE, POSTOPERATIVE VISUAL ACUITY, AND RESTORATION OF OUTER RETINAL LAYERS IN PRIMARY IDIOPATHIC MACULAR HOLE SURGERY.

Baumann C, Kaye S, Iannetta D, Sultan Z, Dwivedi R, Pearce I.

Retina. 2019 Dec 10. doi: 10.1097/IAE.0000000000002707. [Epub ahead of print]

PMID:
31834129
3.

Editorial Comment on: Multicentre investigation on the influence of climate in penile prosthesis infection.

Grice PT, Pearce I, Modgil V.

Int J Impot Res. 2019 Oct 25. doi: 10.1038/s41443-019-0209-9. [Epub ahead of print] No abstract available.

PMID:
31654051
4.

Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema.

Pearce I, Bailey C, Fletcher E, Ghanchi F, Rennie C, Santiago C, Napier J, Yang Y.

Eye (Lond). 2019 Oct 16. doi: 10.1038/s41433-019-0615-8. [Epub ahead of print]

PMID:
31619777
5.

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F.

Br J Ophthalmol. 2019 Aug 5. pii: bjophthalmol-2019-314251. doi: 10.1136/bjophthalmol-2019-314251. [Epub ahead of print]

6.

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.

Chakravarthy U, Pearce I, Banerjee S, Burton BJL, Downey L, Gale R, Patel J, Patra S, Sivaprasad S, Stevenson M, Lupton S.

BMJ Open Ophthalmol. 2019 Apr 30;4(1):e000226. doi: 10.1136/bmjophth-2018-000226. eCollection 2019.

7.

Dexamethasone implant for non-infectious uveitis: is it cost-effective?

Squires H, Bermejo I, Poku EN, Cooper K, Stevens J, Hamilton J, Wong R, Denniston AK, Pearce I, Quhill FM.

Br J Ophthalmol. 2019 Nov;103(11):1639-1644. doi: 10.1136/bjophthalmol-2018-312765. Epub 2019 Feb 11.

8.

Adalimumab for non-infectious uveitis: is it cost-effective?

Bermejo I, Squires H, Poku EN, Cooper K, Stevens JW, Hamilton J, Wong R, Pearce I, Quhill FM, Denniston AK.

Br J Ophthalmol. 2019 Nov;103(11):1633-1638. doi: 10.1136/bjophthalmol-2018-312756. Epub 2019 Feb 6.

9.

ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial.

Forbes R, Ali A, Abouhajar A, Brennand C, Brown H, Carnell S, Chadwick T, Eardley I, Lecouturier J, Mossop H, Pearce I, Pickard R, Thiruchelvam N, Walton K, Wilkinson J, Harding C.

Trials. 2018 Nov 9;19(1):616. doi: 10.1186/s13063-018-2998-4.

10.

Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review.

Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M.

Diabetes Obes Metab. 2019 Mar;21(3):467-478. doi: 10.1111/dom.13550. Epub 2018 Oct 29.

11.

Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathy.

Agorogiannis EI, Pearce IA, Yadav S, Parry DG, Beare NAV.

Eye (Lond). 2018 Nov;32(11):1731-1739. doi: 10.1038/s41433-018-0168-2. Epub 2018 Jul 12.

12.

Accounting for spatially heterogeneous conditions in local-scale surveillance strategies: case study of the biosecurity insect pest, grape phylloxera (Daktulosphaira vitifoliae (Fitch)).

Triska MD, Powell KS, Collins C, Pearce I, Renton M.

Pest Manag Sci. 2018 Dec;74(12):2724-2737. doi: 10.1002/ps.5057. Epub 2018 Jun 28.

PMID:
29707884
13.

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).

Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators.

Acta Ophthalmol. 2018 Dec;96(8):e942-e949. doi: 10.1111/aos.13771. Epub 2018 Apr 25.

14.

A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults.

Squires H, Poku E, Bermejo I, Cooper K, Stevens J, Hamilton J, Wong R, Denniston A, Pearce I, Quhill F.

Health Technol Assess. 2017 Nov;21(68):1-170. doi: 10.3310/hta21680. Review.

15.

Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Gekkieva M, Barnes E, Das Gupta A, Wenzel A, Pearce I; BRIGHTER Study Group.

Ophthalmology. 2017 Dec;124(12):1778-1787. doi: 10.1016/j.ophtha.2017.06.027. Epub 2017 Aug 12. Erratum in: Ophthalmology. 2018 Mar;125(3):463.

16.

Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration in Caucasians.

Yadav S, Parry DG, Beare NAV, Pearce IA.

Br J Ophthalmol. 2017 Oct;101(10):1377-1380. doi: 10.1136/bjophthalmol-2016-310074. Epub 2017 Mar 7.

PMID:
28270486
17.

Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, Wenzel A, Barnes E, Gekkieva M, Pilz S, Monés J; BRIGHTER study group.

Ophthalmology. 2016 Jun;123(6):1332-44. doi: 10.1016/j.ophtha.2016.02.030. Epub 2016 Mar 30.

18.

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.

Larsen M, Waldstein SM, Boscia F, Gerding H, Monés J, Tadayoni R, Priglinger S, Wenzel A, Barnes E, Pilz S, Stubbings W, Pearce I; CRYSTAL Study Group.

Ophthalmology. 2016 May;123(5):1101-11. doi: 10.1016/j.ophtha.2016.01.011. Epub 2016 Feb 17.

19.

Infection of Penile Prostheses in Patients with Diabetes Mellitus.

Christodoulidou M, Pearce I.

Surg Infect (Larchmt). 2016 Feb;17(1):2-8. doi: 10.1089/sur.2015.164. Epub 2015 Oct 1. Review.

PMID:
26426099
20.

Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.

Pearce I, Banerjee S, Burton BJ, Chakravarthy U, Downey L, Gale RP, Gibson J, Pagliarini S, Patel J, Sivaprasad S, Andrews C, Brittain C, Warburton J; RELIGHT Study Group.

Ophthalmology. 2015 Sep;122(9):1811-9. doi: 10.1016/j.ophtha.2015.05.038. Epub 2015 Jul 3.

PMID:
26150052
21.

Entoptic perceptions of spiral waves and rare inward spirals.

Pearce I.

Chaos. 2015 Jun;25(6):063109. doi: 10.1063/1.4922253.

PMID:
26117103
22.

Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.

Gerding H, Monés J, Tadayoni R, Boscia F, Pearce I, Priglinger S.

Br J Ophthalmol. 2015 Mar;99(3):297-304. doi: 10.1136/bjophthalmol-2014-305041. Epub 2014 Jul 29. Review.

23.

Let's chat: bedside reporting in the ED.

Pearce IS, McCarry N.

Nursing. 2014 Aug;44(8):15-7. doi: 10.1097/01.NURSE.0000451534.55587.4c. No abstract available.

PMID:
25025245
24.

Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review.

Glanville J, Patterson J, McCool R, Ferreira A, Gairy K, Pearce I.

BMC Ophthalmol. 2014 Jan 21;14:7. doi: 10.1186/1471-2415-14-7. Review.

25.

Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema.

Owen ME, Beare NA, Pearce IA, Mewar D.

Retina. 2012 Nov-Dec;32(10):2179; author reply 2179-80. doi: 10.1097/IAE.0b013e31826e8589. No abstract available.

PMID:
23047305
26.

Bilateral viral retinitis in a patient with immune deficiency because of purine nucleoside phosphorylase deficiency.

Kumar A, Ziahosseini K, Saeed MU, Pearce IA, Beare NA.

Retin Cases Brief Rep. 2012 Spring;6(2):153-5. doi: 10.1097/ICB.0b013e318218f37e.

PMID:
25390949
27.

Retrospective review of 50 eyes with long-term silicone oil tamponade for more than 12 months.

Morphis G, Irigoyen C, Eleuteri A, Stappler T, Pearce I, Heimann H.

Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):645-52. doi: 10.1007/s00417-011-1873-8. Epub 2011 Dec 4.

PMID:
22138760
28.

Use of Staurenghi lens angiography in the management of posterior uveitis.

Reeves GM, Kumar N, Beare NA, Pearce IA.

Acta Ophthalmol. 2013 Feb;91(1):48-51. doi: 10.1111/j.1755-3768.2011.02200.x. Epub 2011 Aug 19.

29.

Should assessment of penetrative sexual activity be used as the treatment arbiter in the management of Peyronie's disease?

Dukic I, Thakare N, Pearce I, Payne SR.

Int J Impot Res. 2011 Mar-Apr;23(2):70-5. doi: 10.1038/ijir.2011.6. Epub 2011 Mar 24.

PMID:
21430675
30.

Ketamine-induced vesicopathy: a literature review.

Middela S, Pearce I.

Int J Clin Pract. 2011 Jan;65(1):27-30. doi: 10.1111/j.1742-1241.2010.02502.x. Review.

PMID:
21155941
31.

British Association of Urological Surgeons' suprapubic catheter practice guidelines.

Harrison SC, Lawrence WT, Morley R, Pearce I, Taylor J.

BJU Int. 2011 Jan;107(1):77-85. doi: 10.1111/j.1464-410X.2010.09762.x. Epub 2010 Nov 4. Review.

32.

Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis.

Kenawy N, Cleary G, Mewar D, Beare N, Chandna A, Pearce I.

Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):297-300. doi: 10.1007/s00417-010-1523-6. Epub 2010 Oct 5.

PMID:
20922440
33.

Intravitreal bevacizumab for retinal vein occlusion and early growth of epiretinal membrane: a possible secondary effect?

Marticorena J, Romano MR, Heimann H, Stappler T, Gibran K, Groenewald C, Pearce I, Wong D.

Br J Ophthalmol. 2011 Mar;95(3):391-5. doi: 10.1136/bjo.2009.177287. Epub 2010 Aug 7.

PMID:
20693565
34.

Incidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation.

Campa C, Harding SP, Pearce IA, Beare NA, Briggs MC, Heimann H.

Eye (Lond). 2010 Oct;24(10):1585-9. doi: 10.1038/eye.2010.88. Epub 2010 Jun 11.

PMID:
20539314
35.

The origin of information: are IUGA-specific patient information leaflets the answer?

Hawary A, Sinclair A, Pearce I.

Int Urogynecol J. 2010 Aug;21(8):1001-4. doi: 10.1007/s00192-010-1142-0. Epub 2010 Apr 17.

PMID:
20401466
36.

Paraneoplastic exudative retinal detachment associated with adenocarcinoma of the lung.

Burgess PI, Kenawy N, Pearce IA.

Eur J Ophthalmol. 2010 Sep-Oct;20(5):952-4.

PMID:
20213612
37.

Leukaemia diagnosed as a consequence of haematuria assessment: a case report.

Pisipati S, Lucas G, Pearce I.

Cases J. 2009 Sep 16;2:9289. doi: 10.4076/1757-1626-2-9289.

38.

Transurethral resection of the prostate syndrome: almost gone but not forgotten.

Hawary A, Mukhtar K, Sinclair A, Pearce I.

J Endourol. 2009 Dec;23(12):2013-20. doi: 10.1089/end.2009.0129. Review.

PMID:
19821694
39.

Viral-mediated lysis of microbes and carbon release in the sub-Antarctic and Polar Frontal zones of the Australian Southern Ocean.

Evans C, Pearce I, Brussaard CP.

Environ Microbiol. 2009 Nov;11(11):2924-34. doi: 10.1111/j.1462-2920.2009.02050.x. Epub 2009 Sep 16.

PMID:
19758350
40.

Do neckties and pens act as vectors of hospital-acquired infections?

Pisipati S, Bassett D, Pearce I.

BJU Int. 2009 Jun;103(12):1604-5. doi: 10.1111/j.1464-410X.2009.08440.x. Epub 2009 Mar 5. No abstract available.

41.

Patients' acceptance of repeated invasive urological investigations.

Pisipati S, Hu J, Pearce I.

BJU Int. 2009 Jun;103(11):1453-4. doi: 10.1111/j.1464-410X.2009.08441.x. Epub 2009 Feb 23. No abstract available.

42.

Uveitis triggered by acute onset gastroenteritis.

Cazabon S, Quah SA, Pearce IA, Harding SP.

Int J Clin Pract. 2008 Dec;62(12):1957-8. doi: 10.1111/j.1742-1241.2006.01108.x. No abstract available.

PMID:
19166442
43.

Observational prospective study of the effectiveness in routine clinical practice of verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration.

Murjaneh S, García-Fiñana M, Mahmood S, Lenfestey PM, Taylor SA, Pearce IA, Briggs MC, Heimann H, Harding SP.

Br J Ophthalmol. 2009 Apr;93(4):468-73. doi: 10.1136/bjo.2008.141366. Epub 2008 Dec 15.

PMID:
19074914
44.

Cytomegalovirus retinitis in the absence of HIV or immunosuppression.

Sloan DJ, Taegtmeyer M, Pearce IA, Hart IJ, Miller AR, Beeching NJ.

Eur J Ophthalmol. 2008 Sep-Oct;18(5):813-5.

PMID:
18850564
45.

[Densiron-68 heavy silicone oil in cases of PVR. Anatomic and functional outcomes].

Stappler T, Heimann H, Gibran SK, Groenewald C, Pearce IA, Wong D.

Ophthalmologe. 2009 Apr;106(4):320-6. doi: 10.1007/s00347-008-1798-8. German.

PMID:
18636266
46.

Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment.

Romano MR, Stappler T, Marticorena J, Groenewald C, Pearce I, Gibran SK, Wong D, Heimann H.

Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1541-6. doi: 10.1007/s00417-008-0894-4. Epub 2008 Jul 11.

PMID:
18618126
47.

Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease.

Gandhi JS, Tan LT, Pearce I, Charles SJ.

Eye (Lond). 2009 Mar;23(3):742-3. doi: 10.1038/eye.2008.99. Epub 2008 Apr 11. No abstract available.

PMID:
18404159
48.

Heavy tamponade 2 Densiron 68 in routine clinical practice: anatomical and functional outcomes of a consecutive case series.

Stappler T, Heimann H, Wong D, Gibran SK, Groenewald C, Pearce IA.

Eye (Lond). 2008 Oct;22(10):1360-5. doi: 10.1038/eye.2008.62. Epub 2008 Feb 29.

PMID:
18309331
49.

Peel and peel again.

Gibran SK, Flemming B, Stappler T, Pearce I, Groenewald C, Heimann H, Hiscott P, Wong D.

Br J Ophthalmol. 2008 Mar;92(3):373-7. Epub 2007 Nov 30.

PMID:
18055573
50.

Influence of environmental conditions, bacterial activity and viability on the viral component in 10 Antarctic lakes.

Säwström C, Pearce I, Davidson AT, Rosén P, Laybourn-Parry J.

FEMS Microbiol Ecol. 2008 Jan;63(1):12-22. Epub 2007 Nov 21.

Supplemental Content

Loading ...
Support Center